25 Oct 2016 | Proactive Investors
Abstract: Tekcapital PLC (LON:TEK) investee Belluscura has concluded an oversubscribed US$675,000 funding, valuing the whole company at US$5.25mln.
AIM quoted Tekcapital owns 65% of Belluscura following the equity funding.
Belluscura, a specialist in affordable proprietary medical devices, will use the cash as it works to meet regulatory, safety and quality requirements as it seeks CE Mark certification in Europe.
(UK) Walbrook PR Limited: Tel. +44 (0) 207 933 8780
About Tekcapital – The World’s Largest University Network for Open Innovation
Tekcapital helps clients profit from new, university-developed intellectual properties.
With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.